Abstract. Heat shock factor 1 (HSF1), a main regulator of the heat shock response in eukaryotes, increases cell survival in numerous pathophysiological conditions. The aim of the present study was to o bserve the function of defective HSF1 expression in HEK293T cells. shRNA of human HSF1 was constructed into the retroviral vector pLTHR generating pLTHR-shRNA-HSF1. The shRNA was transiently transfected into HEK293T cells to silence the expression of the HSF1 gene. Cell colony formation, MTT and cell cycle assays were used to analyze the SV40 T-antigen (Ag)-transformed cell proliferation rate. Immunoblotting was used to study the protein expression of HSF1, SV40 T-Ag, p53, p21, heat shock protein 90 (Hsp90), Hsp70 and Hsp25. The results revealed that a deficiency in HSF1 expression inhibited cellular growth. Defective HSF1 upregulated the protein expression of p53, retinoblastoma protein (Rb) and SV40 T-Ag, and reduced the association between SV40 T-Ag and p53/Rb, which resulted in growth inhibition of SV40 T-Ag-transformed cells. In conclusion, HSF1 is involved in the regulation of SV40 T-Ag-induced cell growth and modulates the expression of p53 and Rb proteins.
Introduction
Heat shock factor 1 (HSF1) is a member of the HSF family, which includes HSF1, HSF2, HSF3 and HSF4 (1, 2) . These family members have conserved DNA binding domains that can recognize and bind to the heat shock elements (HSEs) in the promoter of the target gene. HSF1 is the dominant regulator of the heat shock response. Upon heat shock or other stresses, the inactive HSF1 is hyperphosphorylated and translocated into the nucleus, forming the active homotrimmerized HSF1. The active form of HSF1 can initiate heat shock protein transcription by binding to the HSEs. The HSF1-mediated heat shock response not only protects cells from environmental or intracellular stresses, but is also in involved in the regulation of numerous pathological processes, such as inflammation and tumorigenesis (3, 4) .
Accumulating evidence demonstrates that HSF1 plays important roles in the regulation of tumorigenesis and development. HSF1 and its relevant downstream targets, heat shock proteins, are elevated in the majority of types of cancer tissue (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Deletion of HSF1 can inhibit DMBA-induced skin cancer, p53 mutant-induced lymphoma and DEN-induced hepatocellular carcinoma. Inhibition of the chaperone activity of heat shock protein 90 (Hsp90) can induce tumor cell apoptosis (15, 16) . This evidence suggests that HSF1 and its mediated heat shock response can stabilize the homeostasis of highly proliferative tumor cells.
Since HSF1 has been found to be associated with p53 and Ras oncogene-induced tumorigenesis, its roles in the viral oncogene-induced tumorigenesis remain unclear. SV40 is a double-stranded DNA tumor virus. SV40 virus has been isolated from HIV-positive non-Hodgkin lymphoma patient tissues (17) . SV40 can express two early oncoproteins; small t-antigen (t-Ag) and large T antigen (T-Ag). T-Ag has been used to create a transgenic tumor mouse model and to transform cells for in vitro study (18) . T-Ag can transform numerous cell types by interacting with and disrupting the tumor suppression activities of p53 and Rb (19, 20) .
In the present study, a cell colony formation assay, an MTT assay and flow cytometry were used to analyze cell proliferation in SV40 T-Ag-expressing cells. To study the mechanisms of HSF1 in SV40 T-Ag-expressing cells, western blotting and an immunoprecipitation assay were used to observe the expression of HSF1, SV40 T-Ag, p53, p21, retinoblastoma protein (Rb), Hsp90, Hsp70 and Hsp25 proteins. HSF1 genes were silenced using an shRNA technique. The present study provides a theoretical basis for the application of HSF1 as a novel target protein to treat various malignant disorders.
Material and methods
Cell lines and culture. HEK293T cells (referred to as 293T cells; SV40 T-Ag-expressing) and H1299 cells (p53-negative) were obtained from American Type Culture Collection (CRL-6253; Mannassas, VA, USA) and cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco-BRL, Carlsbad, CA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco-BRL), 100 U/ml penicillin and 100 µg/ml streptomycin (Gibco-BRL). The morphological characteristics of cells were observed using an inverted microscope (TS100; Nikon, Tokyo, Japan).
All of the above cells and the plasmids were preserved by the Henan University School of Medicine of Cellular and Molecular Immunology Laboratory (Henan, China).
Plasmid construction. A scramble shRNA plasmid, shRNA-HSF1 plasmid and SV40 T-Ag plasmid (Shanghai Shengong Co., Ltd., Shanghai, China) were established in the present study. shRNA of human HSF1 was constructed into the retroviral vector pLTHR generating the pLTHR-shRNA-HSF1. The shRNA sequence was cloned into the retroviral vector plasmid pLTHR downstream of the U6 promoter. The recombinant plasmid was termed pLTHR-shRNA-HSF1 or, in short, shRNA-HSF1. shRNA of green fluorescent protein cDNA was used as the scramble shRNA. The sequences of the human HSF1 gene were as follows: Forward, 5'-GATCCGTGGACTC-CAACCTGGATAATTCAAGAGATTATCCAGGTTGGAGT CCATATTTTTTGGAAg-3'; reverse, 5'-tcgacTTCCAAAAA ATATGGACTCCAACCTGGATAATCTCTTGAATTATC-CAGGTTGGAGTCCAC G-3' .
shRNA-HSF1 transfection of 293T cells. shRNA of human HSF1 was constructed into the retroviral vector pLTHR generating the pLTHR-shRNA-HSF1. The shRNA was transiently transfected into 293T cells to silence the expression of HSF1. Transfection was performed using Lipofectamine 2000 (Invitrogen Life Technologies, Carlsbad, CA, USA) and scramble shRNA-transfected 293T cells were used as the control group. Complete medium was employed 6 h later and cultivation was continued for 48-72 h, and then the cells were harvested by digesting with the trypsin/EDTA (Tiangen Biotech (Beijing) Co., Ltd., Beijing, China) and obtaining the cell deposits. Western blotting was performed to detect the expression of HSF1.
shRNA-HSF1 and SV40 T-Ag co-transfection into H1299 cells.
HSF1 genes in H1299 cells were silenced using the abovementioned shRNA technique, and SV40 T-Ag genes were also transfected into the H1299 cells. shRNA-HSF1+SV40 T-Ag was transiently transfected into the H1299 cells using Lipofectamine 2000, and H1299 cells transfected with scramble shRNA+SV40 T-Ag were used as the controls. Complete medium was employed 6 h later and cultivation was continued for 48-72 h, prior to harvesting. Western blotting was performed to detect the expression of HSF1 and SV40 T-Ag.
MTT assay to examine cell growth. The 293T cells (shRNA-HSF1-and scramble shRNA-transfected) were suspended in DMEM medium containing 10% FBS (Hyclone, Novato, CA, USA). A total of 200 µl of the medium containing 800 cells was plated into six 96-well plates. Each plate possessed all two cell types (including shRNA-HSF1-transfected cells and scramble shRNA cells), which consisted of 200 µl DMEM only, and all groups had seven after holes. The cells were cultivated in 20 µl MTT. Incubation was continued for 4 h and then the supernatant was discarded, prior to the addition of 150 µl dimethylsulfoxide (Sigma, St. Louis, MO, USA) and 10 min of oscillation to dissolve the formazan crystals. The light absorption value was examined by Thermo Multiskan Ascent (Nicolet Evolution 300; Thermo Fisher Scientific, Waltham, MA, USA) at OD490 and then the cell growth curve was drawn with the light absorption (Y-axis) against time (X-axis). The remaining plates were treated using the same procedure.
Cell cycle assay. A total of 1x10
6 293T cells (shRNA-HSF1-and scramble shRNA-transfected, respectively) were collected using three tubes for each type of cells at the different points of the cell cycle. The cells were washed twice with PBS, fixed overnight in precooled 70% alcohol and then washed twice with precooled PBS. Subsequently, the cells were resuspended in 500 µl propidium iodide solution (Sigma; containing 50 µg/ml RNase-A) and incubated for 30 min in the dark at room temperature. Following this, the quantity of DNA was detected using flow cytometry (FACS Calibur; BD Biosciences, San Jose, CA, USA).
Flat colony-forming assay. The 293T cells (shRNA-HSF1-and scramble shRNA-transfected) were cultured for 24 h and adjusted to a final concentration of 1x10³cells/ml in DMEM, following digestion by pancreatin. A total of 200 µl of the solution was plated into six-well plates and all wells were refilled to 10 ml with DMEM containing 10% FBS. All of the plates were kept in a humidified atmosphere containing 5% CO 2 at 37˚C for 2 weeks. The incubation was terminated when visible clones appeared. The plates were washed twice with PBS, fixed by 5 ml of carbinol for 15 min, stained by hematoxylin for 10 min, washed by water to return blue, dried in air and then the visible clones were counted.
Western blotting. The 293T (shRNA-HSF1-and scramble shRNA-transfected) and H1299 (shRNA-HSF1+SV40 T-Agand scramble shRNA+SV40 T-Ag-transfected) cells were lysed with cell lysis buffer containing protease inhibitors to obtain the total proteins. The protein concentrations were measured and the lysates were separated under 10% SDS-PAGE gel (Tiangen Biotech (Beijing) Co., Ltd.). The proteins were transferred onto nitrocellulose membranes (Millipore, Billerica, MA, USA), which were blocked with Tris-buffered saline and Tween 20 (Sigma) containing 5% non-fat dried milk for 1 h at room temperature. The membranes were incubated with primary mouse monoclonal antibodies, including anti-HSF1, -Hsp25, -Hsp70, -heat shock cognate 70 (Hsc70), -Hsp90, -SV40 T-Ag, -p53, -Rb, -p21 and -β-actin (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) at 4˚C overnight. Subsequently, the membranes were incubated with secondary anti-mouse polyclonal antibodies (Santa Cruz Biotechnology, Inc.) for 1 h and then developed using enhanced chemiluminescence (P0018; Biyuntian Biotechnology Institute, Beijing, China), before being exposed to X-ray film. Images of the bands were captured and then analyzed. Statistical analyses. The data are expressed as the mean ± standard deviation. Analysis of the gray values of the protein bands obtained by western blotting was performed using Quantity One software (Bio-Rad, Hercules, CA, USA). The optical density values represent the protein expression levels. Statistical analysis of the data was performed using SPSS 13.0 (SPSS, Inc., Chicago, IL, USA). Student's t-test was used for analyzing the paired data that were normally distributed. Comparisons among the values of more than two groups were performed by one-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference.
Results

Defective HSF1 inhibits 293T cell proliferation.
The MTT assay demonstrated that the growth of the scramble shRNA-transfected 293T cells was faster than that of the shRNA-HSF1-transfected 293T cells (P<0.01; Fig. 1A ). These results demonstrated that Hsf1 promotes 293T cell proliferation. The outcomes of the cell cycle assay demonstrated that the percentage of scramble shRNA-transfected cells in G0/G1 and G2/M phase was markedly lower than that of the shRNA-HSF1-transfected cells (P<0.01). The percentage of scramble shRNA-transfected cells in S phase was greater than that of the shRNA-HSF1-transfected cells (P<0.05; Fig. 1B ). These data implied that the scramble shRNA-transfected cells had a stronger proliferation capacity and higher malignancy degree compared with the shRNA-HSF1-transfected cells.
The clone formation rate of the scramble shRNA-transfected 293T cells and the shRNA-HSF1-transfected 293T cells Fig. 2 ). This implied that the scramble shRNA-transfected cells had stronger proliferation capacity and higher malignancy degree compared with the shRNA-HSF1-transfected cells.
HSF1 is involved in p53, Rb, p21, Hsp25 and SV40 T-Ag expression.
In order to determine the regulatory roles of HSF1 on p53 and Rb, the expression of HSF1 in 293T cells. The western blotting results demonstrated that Rb, p53, p21, Hsp25 and SV40 T-Ag expression was upregulated in the HSF1-silenced cells compared with the scramble shRNA-transfected cells (Fig. 3) . However, no change was observed in the expression of Hsp70, Hsp90 and Hsc70 following the silencing of HSF1 in 293T cells (Fig. 3) . The results suggest that HSF1 is involved in regulation of the protein expression of Rb, p53, and SV40 T-Ag.
HSF1 regulates SV40 T-A, Rb and p21 protein expression.
To investigate the correlations among p53, Rb and SV40 T-Ag, shRNA-HSF1 and SV40 T-Ag were transiently transfected into H1299 cells. H1299 cells are p53-deficient cells, which further facilitated the determination of the effect of HSF1 on Rb and SV40 T-Ag. The results indicated that silencing of HSF1 in H1299 cells caused an upregulation of Rb and SV40 T-Ag protein expression. However, the expression of Hsp70 and Hsp90 was not significantly different between the two cell types (scramble shRNA+SV40 T-Ag-and shRNA-HSF1+SV40 T-A g-transfected). Additionally, p53 was not detected in either of these two cell types (Fig. 4) . These results demonstrated that HSF1 regulates SV40 T-Ag, Rb and p21 protein expression.
SV40 T-Ag binds to p53 and Rb in scramble shRNA 293T cells.
SV40 T-Ag is the onocoprotein that binds to p53 and Rb leading to cell transformation (19, 20) . p53, Rb and SV40 T-Ag are all upregulated in HSF1-silenced cells, suggesting a disruption in the interaction among the three proteins. The present immunoprecipitation results indicate that the interactions between SV40 T-Ag and p53, and between SV40 T-Ag and Rb, were weak in shRNA-HSF1-transfected 293T cells compared with the scramble shRNA 293T-transfected cells. In addition, no SV40 T-Ag binding Hsp70 conjugates were identified in the two cell types (Fig. 5) .
Discussion
HSF1, a main regulator of the heat shock response in eukaryotes, can increase the cell survival in a number of pathophysiological conditions. HSF1 not only regulates the expression of Hsps and stress proteins, but also modulates the expression of numerous other non-Hsp genes, which affect multiple biological functions of organisms. The activity of HSF1 is a major factor that regulates the expression of Hsps in tumor tissues, and its over expression is detected in numerous malignant tumor tissues, in which it regulates the development and metastasis of tumor cells by orchestrating a network of different signaling pathways (15) .
SV40 induces normal mammalian cell tumorigenesis through SV40 T-Ag, which is a production of viral cancer genes. When SV40 T-Ag binds to p53 and Rb the functions of p53 and Rb are deactivated, as is the activation of p21, which facilitates malignant transformation (20, 21) . The involvement of HSF1 in association with SV40 T-Ag in various malignancies remains unclear; thus, exploiting the regulatory mechanisms of HSF1 is of great theoretical significance and practical application value.
HSF1, a potent regulatory factor in tumorigenesis, facilitates tumorigenesis and development by promoting cell malignant transformation (23) . Hoang et al (24) first reported the genesis of human prostate cancer associated with high expression of HSF1. In prostate cancer tissue, enhanced expression of HSF1 and Hsp was found to be concordant with a higher degree of malignancy. It has been demonstrated that using shRNA interference technology to silence HSF1 can significantly reduce the survival of different human cancer cell lines, including breast cell lines (15) . However, the use of shRNA interference technology to silence HSF1 in normal cells has little effect on cell growth and survival. This indicates that tumor cells depend on HSF1 more than normal cells, and that HSF1 may promote tumor formation and development (6, 7) .
T he present st udy demonst rated that HSF1 +/+ scramble shRNA-transfected 293T cells grew faster than shRNA-HSF1-transfected 293T cells (Student's t-test, P<0.001). Furthermore, the cloning efficiency of HSF1 +/+ scramble shRNA-transfected cells was improved compared with that of the shRNA-HSF1-transfected cells (T-test, P<0.01). These results indicated that the absence of HSF1 inhibited 293T cell proliferation. These results are consistent with previous data, similarly revealing that HSF1 enhances 293T cell growth and survival (6, 7) . The cell cycle comprises of the mitotic phase (M) and interkinesis (G1, S and G2) on the basis of the quantity of DNA in cells. It is stated that the G2 phase, S phase and M phase reflect the proliferative activity of cells. In the study of tumor pathology, the S phase fraction is usually the standard to determine tumor proliferation rate (25) . In the present study, cell cycle analysis was performed and it was identified that HSF1 +/+ scramble shRNA-transfected 293T cells had a larger proportion of cells in the S and G2 phases compared with that of shRNA-HSF1-transfected 293T cells (P<0.05). The scramble shRNA-transfected cells had a smaller proportion of cells in the G1 phase compared with that of HSF1-silenced cells (P<0.01). These results indicated that the scramble shRNA-transfected cells had a greater proliferative capacity than that of the HSF1-silenced cells.
SV40 T-Ag is capable of combining with p53 and Rb, which induces cell transformation of cancer proteins (21, 25) . Our results indicated that defective Hsf1 inhibited the SV40T-ag-transformed cell growth and resulted in cell cycle G1/G0 arrest. Therefore, it was hypothesized that HSF1 may be associated with the p53 and Rb signal pathway. The present study revealed an increased expression of SV40 T-Ag, p53, Rb and p21 proteins in shRNA-HSF1-transfected 293T cells as compared with that in scramble shRNA-transfected 293T cells. In addition, the p53-negative H1299 cells were used, which were transfected with SV40-Ag simultaneously to HSF1-silencing. When observing the correlation among HSF1, p53 and Rb, the results also demonstrated that HSF1 is associated with the p53 and Rb signaling pathway.
In HSF1-silenced cells, p53, Rb and SV40 T-Ag protein expression was upregulated. This suggested that there was disruption in the interaction among the three proteins. The immunoprecipitation experimental results identified that in the scramble shRNA-transfected 293T cells, the interactions between SV40 T-Ag and p53 protein, and between SV40 T-Ag and Rb protein, were relatively enhanced and the cells grew more rapidly. However, in the shRNA-HSF1-transfected 293T cells, the interactions between SV40 T-Ag and p53 protein, and between SV40 T-Ag and Rb protein, were relatively weak and the cell growth was slower.
In conclusion, silencing of HSF1 resulted in the upregulation of SV40 T-Ag, Rb, p53 and p21 protein expression, the disruption of binding between SV40 T-Ag and p53/Rb protein, and the inhibition of SV40 T-Ag-induced 293T cell growth. The results suggest that HSF1 promotes the SV40 T-Ag-induced cell proliferation. Furthermore, defective HSF1 causes p53 and Rb protein accumulation, which may be correlated with the slow growth of shRNA-HSF1 in 293T cells. The results demonstrate that HSF1 is involved in the regulation of SV40 T-Ag-induced cell growth and modulates the expression of p53 and Rb proteins.
